Dr. Julie Rosenberg has proven expertise in building and managing comprehensive drug safety programs. At Boehringer Ingelheim, she served as Associate Director, Global Pharmacovigilance, where she established and maintained systems to ensure patient safety and compliance.
She has subsequently developed and led a fully operational pharmacovigilance program for a midsized biopharma company. Her leadership capabilities have been instrumental in creating and scaling a drug safety department tailored to the unique needs of a growing organization.
Expertise in
Global Drug Safety Systems
Dr. Rosenberg has a deep understanding of global pharmacovigilance standards. From her work at Boehringer Ingelheim to her leadership in smaller biotech firms, she is well-versed in designing systems that comply with international regulatory requirements.
Her approach combines robust technical knowledge with a collaborative mindset, enabling her to create scalable solutions that work alongside any company’s needs.
Comprehensive Oversight and Strategic Execution
Dr. Rosenberg’s pharmacovigilance expertise includes full program lifecycle oversight. She has successfully managed tactical tasks, including single-case and aggregate safety review, while aligning strategic initiatives with organizational goals.
Her work has also included partnering with contract research organizations (CROs) to ensure seamless execution of pharmacovigilance systems, meeting both regulatory and operational benchmarks. Additionally, her deep database knowledge and hands-on approach make her a trusted advisor and problem solver in addressing the day-to-day complexities of drug safety.
Contact
Partner With
Dr. Rosenberg
Dr. Rosenberg’s pioneering solutions for pharmacovigilance deliver results that ensure compliance, safety, and success for any biopharma company.